Abstract A171: A potent and selective PI3K inhibitor, INK1117, targets human cancers harboring oncogenic PIK3CA mutations.
暂无分享，去创建一个
Shunyou Wang | Katrina Chan | C. Rommel | Yi Liu | M. R. Janes | P. Ren | Michael Martin | Katti A. Jessen | Lian-Sheng Li | L. Kessler | Jeff M Kucharski | L. Darjania | U. Banerjee | M. Elia | Xin Guo | J. Staunton | L. Lan | J. Stewart | Angelina Luzader | K. Jessen | Pingda Ren | Jeff M. Kucharski